Subclinical mastitis causes chronic pain and production loss without overt signs. Systematic identification through somatic cell count monitoring and targeted treatment improves welfare.
Subclinical mastitis is a welfare problem hidden from routine observation. Without visible signs — no swollen quarter, no abnormal milk — affected cows show no overt pain indicators that prompt treatment. Yet research using validated pain measures, including the Cow Pain Scale and behavioral indicators, consistently demonstrates that subclinically infected cows show elevated pain scores compared to bacteriologically negative cows. This hidden, chronic pain affects millions of dairy cows globally.
The welfare harm of subclinical mastitis is compounded by its duration. Chronic infections with contagious pathogens may persist for months or years without spontaneous clearance. During this extended period, affected cows experience ongoing low-grade quarter pain, immune activation, and metabolic consequences of persistent infection — a prolonged welfare burden that routine treatment could significantly reduce.
Monthly SCC monitoring identifies problem herds and, with cow-level data, identifies chronically infected individuals. Targeted dry cow therapy — treating identified infected quarters at drying off — provides the highest cure rates and most welfare improvement. The AHDB mastitis management programme provides evidence-based decision support tools for dairy farmers and vets.